Forget what drugs were approved. What drugs performed well? – MedCity News https://t.co/TladzX40kF — The Propell Group (@ThePropellGroup) December 5, 2017
FDA clears AliveCor’s Kardiaband as the first medical device accessory for the Apple https://t.co/PAd52wNkas via @techcrunch — The Propell Group (@ThePropellGroup) December 5, 2017
Is it time to say goodbye to https://t.co/rJhSrm7ABA? – MedCity News https://t.co/uiNhJm1qZx — The Propell Group (@ThePropellGroup) December 4, 2017
Sanofi leads charge against counterfeit drugs via @FT#HealthTech https://t.co/DMiKd4BXog — The Propell Group (@ThePropellGroup) December 4, 2017
https://t.co/gatZNbxvlB — The Propell Group (@ThePropellGroup) December 4, 2017
The Doyenne of DNA Says: Just Chillax With Your Ex – The New York Times https://t.co/d0j2ijXyqO — The Propell Group (@ThePropellGroup) December 4, 2017
Data Sharing from Clinical Trials — A Research Funder’s Perspective — NEJM https://t.co/VAZQdNwgLr — The Propell Group (@ThePropellGroup) December 4, 2017
Europe’s open digital economy? | The Economist – Android https://t.co/Nqa1nOrM3c — The Propell Group (@ThePropellGroup) December 4, 2017
Here Are The Asian Smartphone Upstarts Gunning To Displace Apple, Samsung, In The Region #healthtech https://t.co/mUkUn4jQD7 — The Propell Group (@ThePropellGroup) December 4, 2017
CVS Health to buy Aetna for $68bn via @FT https://t.co/9IECkqHWo6 — The Propell Group (@ThePropellGroup) December 4, 2017